HCM experts discuss the importance of shared decision-making in the treatment of patients with HCM with or at risk for arrhythmias, including patient perspectives. The prevalence of symptomatic and asymptomatic atrial fibrillation requires shared decision-making between patients and providers regarding initiation of oral anticoagulation and global management strategy (rate vs rhythm control). Likewise, this episode will highlight factors to consider when deciding on ICD placement, particularly for primary prevention of sudden cardiac death.

Claim CE and MOC at

· https://education.heart.org/productdetails/living-arrhythmic-consequences-hypertrophic-cardiomyopathy-hcm